The economic development of Qatar alongside the resultant lifestyle changes in the last few decades has contributed to increasing rates of obesity, diabetes mellitus and hypertension with consequent increased incidence and prevalence of chronic kidney disease and end-stage-renal-disease (ESRD). This article describes renal replacement therapy (RRT) services in Qatar and their evolution in response to challenges posed by the growth of ESRD with reference to regional and international data. It covers the history of RRT, highlighting significant advances in chronological order, as well as providing an overview of the current status of RRT in the multicultural and socioeconomically diverse society that inhabits Qatar. Finally, it casts a glance into the future, predicting how RRT services will further evolve to address the current limitations.
Introduction
Qatar is a peninsula extending north from Saudi Arabia into the Arabian Gulf, covering an overall area of 11,627 km, with a population of 2.5 million [1] . Doha is the capital and most populous city of the State of Qatar. Blessed with the world's third largest natural gas field, Qatar has the world's highest per capita GDP [2] . The economic boom experienced by Qatar in recent years has been associated with a surge in international migration of workers from developing countries, evidenced by an annual population growth of 11.8% in 2004 and 18.9% in 2008. Consequently, approximately 85% of the population is non-citizen.
Inappropriate dietary and lifestyle patterns that have accompanied economic development have led to increasing rates of obesity and chronic non-communicable diseases (NCDs). Chronic kidney disease (CKD) and end-stage-renal-disease (ESRD) are key determinants of poor health outcomes of these conditions and put a significant economic burden on health systems.
This article describes the evolution of renal replacement therapy (RRT) services in Qatar, a multi-cultural society with substantial socioeconomic diversity, to combat the challenges posed by the growth of ESRD into an international perspective using information from different renal registries. International comparisons should however be interpreted with caution as data collection methods vary across countries. The incidence and prevalence of RRT in Qatar was analyzed using aggregated data from each hospital/dialysis center; hence adjustment on age, gender, co-morbidities or cause of ESRD was not possible. It is also important to appreciate that prevalence of RRT modalities in a country depends not only on underlying burden of ESRD, but also on access to treatment, healthcare infrastructure, treatment outcomes, and in case of kidney transplantation-organ availability, and cultural beliefs.
Evolution of RRT Services in Qatar
The evolutionary history of the development of RRTs in Qatar is summarized in Table 1 . Although the first hospital of Qatar, Rumailah Hospital, was opened in 1957, dialysis services were not available until 1976; Qatari citizens used to travel and live abroad for maintenance hemodialysis (HD). In 1976, peritoneal dialysis (PD) was started for acute kidney injury (AKI). PD catheters used to be inserted in the procedure room of a medical ward by a medical registrar who had previous international experience in dialysis therapies. Five years later, a 5-station HD unit was established to treat patients with severe AKI or ESRD-this unit was managed by one physician, 2 dialysis nurses and 2 dialysis technicians. 
Epidemiological Transition of RRT-Treated ESRD in Qatar
Dietary behaviors and sedentary lifestyle patterns that have accompanied the economic development of the country in the last few decades have contributed to increasing rates of obesity in the Qatari community. Obesity appears to be a particular problem for the region of Doha, where almost 40% of the population is considered obese [3] . This has been coupled with increasing prevalence of chronic non-communicable diseases (NCDs), such as diabetes mellitus and hypertension [4] . Qatar is one of the top ten countries listed as having the highest DM prevalence worldwide [5] . The WHO STEPS survey of 2496 adults conducted in Qatar in 2012 illustrated that an estimated 17% of the Qatari citizens had diabetes mellitus and 33% had hypertension [4] . The situation is compounded by the influx of south-Asian immigrants who also tend to have a high prevalence of diabetes and metabolic syndrome [6] .
Increasing prevalence of obesity, diabetes mellitus and hypertension-the established risk factors for CKD-has not only increased the burden of CKD and ESRD [4] , but has also influenced the statistics on etiology of ESRD in Qatar.
The percentages of patients starting RRT for ESRD due to diabetes has increased from 19% in 1991 to 48% in 2016 (50 pmp); a trend seen in many gulf countries [7] . Inversely, ESRD due to primary glomerulonephritis has decreased from 33.3% in 1991 to 13% (13.6 pmp). In comparison, the unadjusted incident rates of RRT for ESRD due to diabetes and glomerulonephritis have been reported to be 30% (40 pmp) and 10% (13 pmp) respectively in Europe [8] .
Analysis of Qatar's annual renal data revealed that the prevalence of RRT treated ESRD was 659 pmp on 31st December 2016; 261 new cases of ESRD started RRT in 2016, generating an (unadjusted) incidence rate of 104 pmp. This represents a 34% increase in the incidence of RRT compared to 2013. Although these incidence rates are seemingly lower than those reported in the USA [9], most European countries [8] , Australia or New Zealand [10] , Qatar's population is significantly distorted demographically, thereby skewing the crude incidence rates. This is due to the fact that the non-citizen community, which forms the major bulk of the total population, is relatively younger; approximately 90% are in the working-age groups (15 to 64 years). Thus, the median age in Qatar is 32.6
years [11] ; vs 37.8 years in the USA [12] . Importantly, the segment of population with high ESRD incidence-representing people aged 65 and over-constitutes only 1% of the total population in Qatar [11] vs 14.5% in the USA [12] .
On December 31, 2016, 44.4% of all prevalent patients on RRT were receiving HD therapy, 10.7% were being treated with PD, and 44.4% had a functioning kidney transplant ( Figure 1 ). Prevalence of these RRT modalities is quite similar to aggregated estimates from Europe [8] and Australia [10] . The United States
Renal Data System (USRDS) and Saudi Center for Organ Transplantation 
Provision of RRTs in Qatar
RRT in Qatar is provided only in Ministry of Public Health (MoPH) government hospitals; non-MoPH government or private for-profit HD facilities do not exist.
The government is focusing on health reform by the development of medical insurance but at present, funding is primarily based on HMC healthcare budget.
Government health spending per capita is US$ 2882; the highest in the Middle
East & Africa [9] . It is noteworthy that patients in Qatar have one of the world's lowest burdens of health expenditure, similar to the top performing OECD countries [14] . This is driven by free/highly subsidized public healthcare to all Qatari citizens and non-citizens-a key indicator of equity in removing immediate financial barriers to healthcare. 
Current Status of RRTs in Qatar
All major modalities of RRT are available; the geographical locations of the RRT facilities conform to the population density distribution in the country ( Figure   3 ). The unadjusted 1-year and 5-year survival rates of the HD patients have previously been reported to be 84% and 53% respectively [19] , which is comparable with or superior to larger international registries (USRDS, 77.7% and 42.6%) [8] Open Journal of Nephrology 
Hemodialysis

Peritoneal Dialysis
Since its initiation in 1997, PD has been increasingly utilized as a mode of RRT.
Currently (July 2017), 197 patients (10.7% of RRT patients; 20% of the prevalent dialysis patients) are maintained on PD; the major bulk of which are followed up in Doha although smaller programs also operate in Al Wakra and Al Khor cities.
The percentage of PD utilization in Qatar is significantly higher than that in the USA (6.9%), Europe (5%) or KSA (6%) [8] [9] [13] . This is likely due to cost effectiveness of PD, availability of nurse assisted-home PD as well as in-depth training of the young nephrologists in PD which influences their prescription habits with regards to dialysis modality.
Use of APD has grown markedly in the recent years due to the lifestyle, solute clearance and fluid removal advantages it offers, particularly in fast transporters-50% of the PD patients utilize this modality, which is comparable to the trend in most European countries and New Zealand Overall unadjusted 1-year and 2-year survival (from day 1) is 91% and 77%
respectively [20] which compares favorably to European Dialysis and Transplant Association (EDTA) registry data [8] . Exclusive use of the twin-bag system and a strong focus on patient training and quality improvement, has kept the peritonitis rate low at 0.2 episodes per patient-year. Although these rates are significantly lower than those in Europe (36 pmp), [8] by equipping the country with the legislation necessary to establish deceased 
Kidney Transplantation
Nephrology Workforce
There is evidence that care by nephrologists generally leads to better patient and renal outcomes [9] [23] . Unfortunately, international data suggests that trained nephrology workforce has not grown at pace with the growing disease burden and healthcare needs of patients with kidney disease [24] . In the past Qatar had 
Education and Quality Improvement
Given that education of physicians and patients reduces the risk of progression of kidney disease and/or death [25] , HMC has devoted substantial resources to- 
From Treatment to Prevention of CKD and ESRD-Paradigm Shift in Health Care
To reduce the incidence of ESRD, it is crucial to detect CKD early in its course, as it will provide opportunities for treatment of reversible factors, better management of comorbidities and slowing the rate of progression to ESRD. The MoPH aims to improve awareness and services for diabetes and obesity [14] and has formulated national guidelines for increasing physical activity. A variety of awareness programs such as "We Are Healthy Kids" and "Workplace Wellness
Program" have been introduced. In addition, a national diabetes strategy and action plan has been launched. As part of the national primary health care strategy 2013-2018, the Primary Health Care Corporation (PHCC) is implementing comprehensive screening programs for diabetes, hypertension and kidney disease. This is important because PHCC provides 39% of Qatar's outpatient care. The MoPH has also produced evidence-based algorithms/pathways on screening, diagnosis and management of CKD for primary healthcare providers. These pathways also provide guidance to the primary care physicians regarding timing of referral of patients Open Journal of Nephrology for evaluation/management to the nephrologists. It is believed that early diagnosis and management of the NCDs will reduce the burden of kidney disease in Qatar and provide cost savings for the health care system.
Future of RRT in Qatar; A Glance into the Next Decade
In the future, prevention of CKD and ESRD will become one of the priority areas of public health. The campaign against obesity, diabetes and hypertension will build up substantially and bring together leaders from academia, industry and policy makers of public health. Interventions targeting hypertension, diabetes mellitus and proteinuria with a standardized pharmacological therapy will be implemented rigorously in primary care and supported by specialized hospital care.
Preventative strategies for CKD will take several years to make any meaningful impact-hence it is predictable that the prevalence of RRT-treated ESRD population will increase with time. Current trends in utility of RRT modalities suggest that HD will remain the dominant modality for dialysis in future, necessitating expansion of existing facilities and establishment of new ones. In view of growing cost constraints, it is conceivable that the use of home based therapies-HD and PD will increase appreciably. Patients will be trained comprehensively to perform hemodialysis independently at home, without the assistance of a dialysis nurse. The Qatari government is encouraging the private sector to play a greater role in healthcare provision; it is likely that RRT services will also be offered at private healthcare facilities, especially with the introduction of health insurance. A unified national renal registry database will be established for tracking demographic, clinical and laboratory data, estimating disease burden and monitoring the quality of care. This registry database will also be used for future research and strategic planning for RRT services in Qatar.
Renal transplantation, in particular pre-emptive renal transplantation will increase considerably. The transplant program has developed policies and protocols for desensitization and ABO incompatible transplantation; this will benefit approximately one third of the living donor-recipient pairs in the program who are immunologically incompatible with each other. More renal transplants will be carried out locally as the national and international policies on commercial transplantation become more stringent. Availability of deceased kidney donors will remain a key challenge. Current estimates reveal that family consent rates for organ donation from deceased donors remain at less than 20% [22] . Public awareness campaigns and training of ICU physicians and transplant coordinators will hopefully expand the pool of deceased donors. Expanded criteria deceased organ donors will be utilized more liberally, hence more patients will benefit from transplantation. Donation after cardiac death and kidney paired donation programs will start to maximize transplant rates.
The number of nephrologists will increase to at least 10 pmp or 1 per 75 RRT-treated ESRD patients, approaching the scale among European countries Open Journal of Nephrology and the USA.
Conclusions
Qatar has experienced rapid evolution of RRT in the last four decades. All major modalities of RRT are available, all providing therapeutically effective and individualized care to patients with ESRD, at par with international standards. The services are accessible to all communities independent of their ethnicity or socioeconomic status.
Given the significant rise in the prevalence of NCDs and RRT, it is predictable that HD and CAPD population will continue to grow, requiring development of new dialysis units. However, the government and nephrology community realize that a multipronged integrated approach is required to combat ESRD. It is vital to continue to strengthen policies and programs on healthy lifestyles and NCD prevention, and intensify the efforts to aggressively treat CKD in its early stages at community level. At the same time, it is imperative that further progress in kidney transplantation is made by taking on board new initiatives to expand the organ donor pool and optimizing the use of available donors. Finally, it is incumbent that the nephrology workforce is reinforced. Effective education, training, and professional development of nephrologists, transplant coordinators, dialysis nurses, and technicians will make the greatest difference in providing safe, effective, and compassionate care to every patient with renal disease-reflecting the mission of Hamad Medical Corporation.
